MORF
$34.55
Morphic Holding
$.21
.61%
MORF
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  ($0.85)
Revenue:  $2.83 Mil
Thursday
Feb 23
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MORF reports earnings?
Beat
Meet
Miss

Where is MORF's stock price going from here?
Up
Flat
Down
Stock chart of MORF
Analysts
Summary of analysts' recommendations for MORF
Score
Grade
Pivots
Resistance
$36.79
$35.74
$35.14

$34.09

Support
$33.49
$32.44
$31.84
Tweet
Growth
Description
Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.